文献速递皮肤肿瘤

黑色素瘤作为检测依赖型癌症:全国前瞻性研究中筛查与监测相关的3年检测操作发生率

Melanoma as a detection-dependent cancer: proxy measures of screening and surveillance associated with 3-year incidence of detection procedures for skin cancer in a national prospective study.
PubMed 文献 · Br J Dermatol · 2025-01-01

该研究基于澳大利亚全民医保关联数据,纳入10 674 200名2011-12年无活检或皮肤癌诊断的成人,按2013年索赔分为监测、筛查和未筛查组,比较2014-2016年活检、疑似黑色素瘤切除和确诊黑色素瘤切除的发生率。调整社会人口学因素后,筛查组活检率(RR 2.59,95%CI 2.56-2.63)、疑似黑色素瘤切除率(RR 2.57,95%CI 2.53-2.60)和确诊黑色素瘤切除率(HR 3.32,95%CI 3.24-3.40)均显著高于未筛查组,监测组也呈类似升高,且各随访年份持续存在。

要点

  • 筛查者后续活检率是未筛查者的2.59倍(95%CI 2.56-2.63)。
  • 筛查者确诊黑色素瘤切除风险是未筛查者的3.32倍(95%CI 3.24-3.40)。
  • 监测组同样出现诊断操作和黑色素瘤发生率升高。

核心结论

  • 接受皮肤筛查或监测的人群后续诊断性检查率和黑色素瘤发生率均更高,支持“过度检测循环”假说。

研究设计与样本

  • 前瞻性队列研究,利用澳大利亚全民医保关联数据(2011-2016),纳入10 674 200名成人,排除2011-12年活检或皮肤癌诊断者,按2013年医疗索赔分为监测、筛查和未筛查组,随访2014-2016年检测事件。

主要发现

  • 调整社会人口学因素后,筛查组活检率显著高于未筛查组(RR 2.59,95%CI 2.56-2.63)。
  • 筛查组疑似黑色素瘤切除率显著高于未筛查组(RR 2.57,95%CI 2.53-2.60)。
  • 筛查组确诊黑色素瘤切除率显著高于未筛查组(HR 3.32,95%CI 3.24-3.40)。
  • 监测组后续诊断事件发生率也呈类似升高。
  • 筛查或监测者在各随访年份的检测率和黑色素瘤率均持续升高。

临床怎么用

  • 临床中应认识到皮肤筛查和监测可能增加后续活检及黑色素瘤诊断,需权衡过度检测风险。

局限性

  • 研究未报告筛查间隔、活检指征及病理亚型等细节,无法区分过度诊断与真实风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increased levels of skin detection activities are suspected of driving recent rapid increases in melanoma incidence. While ecological studies report rising rates of skin biopsies in many industrialized populations, few studies have accessed individual-level clinical data to test the hypothesis that people exposed to skin screening and surveillance go on to experience higher levels of biopsies and excisions, and a higher incidence of melanoma. OBJECTIVES: To measure the incidence rates of detection events and melanoma diagnoses in a national cohort during follow-up, stratified according to screening or surveillance activities in the index year. METHODS: We conducted a prospective cohort study of 10 674 200 adults using linked data from Australia's universal health insurance scheme (2011-2016). Participants who underwent biopsies or who were diagnosed with skin cancer in 2011-12 were excluded. We then defined participants as surveilled, screened or unscreened for skin cancer based on medical claims occurring in 2013. We compared rates of biopsies, excisions for suspected melanoma and excisions for histologically confirmed melanoma during follow-up (2014-2016). RESULTS: After adjusting for sociodemographic factors, screened people were significantly more likely than unscreened people to undergo skin biopsies [rate ratio (RR) 2.59, 95% confidence interval (CI) 2.56-2.63], excisions for suspected melanoma (RR 2.57, 95% CI 2.53-2.60) and excisions for confirmed melanoma (hazard ratio 3.32, 95% CI 3.24-3.40) during follow-up. Similarly elevated rates of subsequent diagnostic events were observed for the surveilled group. Importantly, rates of detection and rates of melanoma remained elevated in each of the subsequent years of follow-up among those who were screened or surveilled in the index year. CONCLUSIONS: People undergoing skin screening or surveillance subsequently experience higher rates of diagnostic scrutiny and higher rates of melanoma. Melanomas are common cancers arising on the skin. Each year, more than 16,000 people in the UK are diagnosed with melanoma, and more than 2,000 people die. There is increasing belief that some melanomas will never grow deeply or spread. It is thought that if these spots weren't found by doctors, they wouldn't cause any harm to the patient. A ‘cycle of over-detection’ may explain the apparent ‘epidemic’ of melanoma. That is, as the public becomes more aware of melanoma, more people attend for screening. This leads to more biopsies, which find more slow-growing melanomas. There is some evidence to support this. However, studies done so far have either used aggregated, or been of small size. Therefore, it is not known at a population level whether people who undergo screening go on to have more biopsies and higher rates of melanoma. We conducted a large study of skin cancer detection activities in more than 10 million people. We compared rates of biopsies and tumour removal in people, depending on whether or not they had a skin cancer check at the start of the study. We found that people who had skin cancer check at the start of the study experienced higher rates of skin cancer checks and melanoma during follow-up. This study provides support for ‘cycle of over-detection’, in which skin cancer checks are associated with higher rates of melanoma in the future.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Pandeya N, Olsen CM, Neale RE, et al. Melanoma as a detection-dependent cancer: proxy measures of screening and surveillance associated with 3-year incidence of detection procedures for skin cancer in a national prospective study. Br J Dermatol. 2025. PMID: 39353059. doi:10.1093/bjd/ljae372

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。